The Gist Healthcare Podcast Wednesday, October 29, 2025
Oct 29, 2025
Texas is suing the makers of Tylenol, alleging they concealed autism risks associated with prenatal use. Meanwhile, furloughed CMS employees return to assist with Medicare and ACA enrollments. Cigna is shaking up drug pricing by shifting from rebates to point-of-sale discounts, potentially lowering costs by around 30%. The podcast also touches on CVS's decision to close multiple clinics amid operational shifts, and hints at a study revealing limited doctor access for Medicare Advantage enrollees compared to traditional Medicare.
AI Snips
Chapters
Transcript
Episode notes
Contested Claims About Tylenol And Pregnancy
- Texas alleges Johnson & Johnson hid research linking prenatal acetaminophen to autism and ADHD.
- The scientific link remains unproven and major medical groups still consider acetaminophen the safest pregnancy analgesic.
CMS Recalls Staff Amid Enrollment Uncertainty
- CMS temporarily recalled furloughed staff to support Medicare and ACA open enrollment during the prolonged government shutdown.
- Enrollment uncertainty is heightened as expanded ACA subsidies face expiration without congressional action.
Cigna Moves Away From Rebates
- Cigna's Evernorth will eliminate traditional rebates and pass discounts directly at pharmacy checkout for many members by 2028.
- The company expects brand-name prices to fall about 30% for patients paying full cost under the new model.